Spots Global Cancer Trial Database for young adult
Every month we try and update this database with for young adult cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Wilderness Program for Adolescent and Young Adult Cancer Survivors | NCT04761042 | Cancer | WAYA-Wilderness WAYA-Holiday | 16 Years - 39 Years | Mid Sweden University | |
Meditation, Education, Navigation, & Training Using eHealth: Cancer Adaptation Through Learning Mindful Awareness | NCT05912166 | Cancer | Wakeful Spanish | 18 Years - 39 Years | Northwestern University | |
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | NCT04898894 | Acute Leukemia ... Acute Myeloid L... Refractory Acut... Refractory Acut... | Venetoclax Selinexor Cytarabine Fludarabine Filgrastim Methotrexate methotrexate/hy... | 2 Years - 30 Years | St. Jude Children's Research Hospital | |
Early Onset Colorectal Cancer Detection | NCT06342401 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... | ENCODE | 18 Years - 50 Years | City of Hope Medical Center | |
A Cooking and Eating Study | NCT01079845 | Polycystic Ovar... | Nutrition Educa... | 13 Years - 21 Years | Boston Children's Hospital | |
Symptom Management for YA Cancer Survivors | NCT04035447 | Cancer Young Adult Pain Psychological D... Fatigue Breast Cancer Melanoma Hematologic Can... Germ Cell Tumor Endocrine Cance... | Behavioral Symp... | 18 Years - 39 Years | Duke University | |
Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors | NCT02699996 | Cancer Survivor | Questionnaire A... Telephone-Based... | 18 Years - 29 Years | Rutgers, The State University of New Jersey | |
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer | NCT01618344 | Neoplasms | 15 Years - 29 Years | University of Utah | ||
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
"COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors | NCT05434702 | Health Behavior | Digital Diet Di... NHANES Food Fre... Fitbit data col... Quality of Life... Functional Asse... Godin Exercise ... Zoom interviews | 20 Years - 30 Years | H. Lee Moffitt Cancer Center and Research Institute | |
Early Onset Colorectal Cancer Detection | NCT06342401 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... | ENCODE | 18 Years - 50 Years | City of Hope Medical Center | |
Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients | NCT04448678 | Adolescent Young Adult Cancer | Health Insuranc... Usual Care | 18 Years - 40 Years | University of Utah | |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors | NCT06371768 | Cancer Breast Cancer Colorectal Canc... Sarcoma Lymphoma Testicular Canc... | AYA Educational... AYA STEPS | 18 Years - 39 Years | Duke University | |
Early Onset Colorectal Cancer Detection | NCT06342401 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... | ENCODE | 18 Years - 50 Years | City of Hope Medical Center | |
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer | NCT01618344 | Neoplasms | 15 Years - 29 Years | University of Utah | ||
Evaluation of a Video Game for Adolescents and Young Adults With Cancer | NCT00425139 | Neoplasms | Re-Mission | 13 Years - 29 Years | HopeLab Foundation | |
The Experience of TYAC Offered Ovarian Tissue Cryopreservation | NCT02830061 | Cancer Fertility | Interviews | 13 Years - 25 Years | University of Oxford | |
Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors | NCT02699996 | Cancer Survivor | Questionnaire A... Telephone-Based... | 18 Years - 29 Years | Rutgers, The State University of New Jersey | |
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies | NCT03569605 | Physical Activi... Neoplasms Neoplasms by Si... Cancer | Self-help Intervention | 18 Years - 39 Years | UNC Lineberger Comprehensive Cancer Center | |
The Experience of TYAC Offered Ovarian Tissue Cryopreservation | NCT02830061 | Cancer Fertility | Interviews | 13 Years - 25 Years | University of Oxford | |
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) | NCT03455140 | Cancer Pediatric Solid... Pediatric AML Pediatric ALL | PEG- BCT-100 | 1 Year - 25 Years | University of Birmingham | |
Evaluation of a Video Game for Adolescents and Young Adults With Cancer | NCT00425139 | Neoplasms | Re-Mission | 13 Years - 29 Years | HopeLab Foundation | |
BEFORE Decision Aid Implementation Study | NCT03629509 | Decision Suppor... Breast Neoplasm... Young Adult Evaluation Stud... | BEFORE decision... BEFORE decision... BEFORE decision... | 18 Years - 40 Years | Unity Health Toronto | |
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors | NCT03768336 | Cancer | Waitlist contro... 3RP-AYA | 16 Years - 29 Years | Massachusetts General Hospital | |
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors | NCT03768336 | Cancer | Waitlist contro... 3RP-AYA | 16 Years - 29 Years | Massachusetts General Hospital | |
Exercise and Relaxation Intervention for Young Adult Cancer Survivors | NCT00801008 | Cancer | Exercise and re... | 18 Years - 39 Years | The Miriam Hospital | |
Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors | NCT06171945 | Cancer Physical Activi... Cancer Survivor... Mental Health Obesity | AYA Connect int... Positive Psycho... Positive Psycho... | 18 Years - 39 Years | UNC Lineberger Comprehensive Cancer Center | |
Role of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant Treatment | NCT03002727 | Colorectal Canc... Young Adult | 18 Years - 40 Years | Assiut University | ||
Role of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant Treatment | NCT03002727 | Colorectal Canc... Young Adult | 18 Years - 40 Years | Assiut University | ||
Learning Yoga to eNhance Cancer Survivorship | NCT04301050 | Cancer | Yoga Interventi... | 25 Years - 39 Years | Northwestern University | |
Learning Yoga to eNhance Cancer Survivorship | NCT04301050 | Cancer | Yoga Interventi... | 25 Years - 39 Years | Northwestern University | |
Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia | NCT03186118 | CD 19+ Acute Le... | T-cell Antigen ... | 1 Year - 30 Years | Seattle Children's Hospital | |
Evaluating Procedures for a Study of the AYA Survivors Coping and Emotional Needs Toolkit | NCT06420193 | Depression Cancer Adolescent Young Adult Adult | AYA Survivors C... | 15 Years - 39 Years | East Carolina University | |
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. | NCT06337760 | Neuroendocrine ... Adenocarcinoma | 18 Years - 39 Years | European Institute of Oncology | ||
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer | NCT05732623 | Colorectal Canc... Early Onset Col... Diet Habit Risk Reduction | Semi Quantitati... | 18 Years - 49 Years | San Raffaele University | |
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | NCT04898894 | Acute Leukemia ... Acute Myeloid L... Refractory Acut... Refractory Acut... | Venetoclax Selinexor Cytarabine Fludarabine Filgrastim Methotrexate methotrexate/hy... | 2 Years - 30 Years | St. Jude Children's Research Hospital | |
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer | NCT05732623 | Colorectal Canc... Early Onset Col... Diet Habit Risk Reduction | Semi Quantitati... | 18 Years - 49 Years | San Raffaele University | |
Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco | NCT03238456 | Tobacco Use Tobacco Smoking Tobacco Use Ces... Smoking Smoking Cessati... Smoking, Cigare... | Motivating Paci... | 18 Years - 30 Years | Claremont Graduate University | |
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) | NCT03396575 | Diffuse Intrins... Brain Stem Glio... | TTRNA-DC vaccin... TTRNA-xALT Cyclophosphamid... Dose-Intensifie... Td vaccine Autologous Hema... | 3 Years - 30 Years | University of Florida | |
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia | NCT03932903 | Acute Lymphobla... | AYA ADAPTS (ADh... | 14 Years - 29 Years | Northwestern University | |
Exercise and Relaxation Intervention for Young Adult Cancer Survivors | NCT00801008 | Cancer | Exercise and re... | 18 Years - 39 Years | The Miriam Hospital | |
Web-based Physical Activity Intervention for Young Adult Cancer Survivors | NCT00791375 | Cancer | Physical activi... | 18 Years - 39 Years | The Miriam Hospital | |
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma | NCT03244306 | Leukemia | Patient-derived... | 1 Year - 26 Years | Seattle Children's Hospital | |
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia | NCT03932903 | Acute Lymphobla... | AYA ADAPTS (ADh... | 14 Years - 29 Years | Northwestern University | |
Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas | NCT03334305 | Malignant Gliom... High Grade Glio... | TTRNA-DC vaccin... Dose-intensifie... Autologous Hema... TTRNA-xALT Td vaccine | 3 Years - 21 Years | University of Florida | |
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma | NCT03244306 | Leukemia | Patient-derived... | 1 Year - 26 Years | Seattle Children's Hospital | |
Risk Information and Skin-cancer Education for Undergraduate Prevention | NCT03979872 | Melanoma Young Adult | MC1R Genetic Te... Skin Cancer Edu... UV Photo | 18 Years - | University of Utah | |
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) | NCT03455140 | Cancer Pediatric Solid... Pediatric AML Pediatric ALL | PEG- BCT-100 | 1 Year - 25 Years | University of Birmingham | |
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies | NCT03569605 | Physical Activi... Neoplasms Neoplasms by Si... Cancer | Self-help Intervention | 18 Years - 39 Years | UNC Lineberger Comprehensive Cancer Center | |
Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL) | NCT04225676 | Acute Lymphobla... | Tisagenlecleuce... | 2 Years - 25 Years | Novartis |